rs1554973
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_138554.5(TLR4):c.*3886T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.374 in 151,840 control chromosomes in the GnomAD database, including 14,102 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 14102 hom., cov: 31)
Exomes 𝑓: 0.33 ( 0 hom. )
Consequence
TLR4
NM_138554.5 3_prime_UTR
NM_138554.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.808
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.707 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLR4 | NM_138554.5 | c.*3886T>C | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000355622.8 | NP_612564.1 | ||
TLR4 | NM_003266.4 | c.*3886T>C | 3_prime_UTR_variant | Exon 4 of 4 | NP_003257.1 | |||
TLR4 | NM_138557.3 | c.*3886T>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_612567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLR4 | ENST00000355622.8 | c.*3886T>C | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_138554.5 | ENSP00000363089.5 | |||
ENSG00000285082 | ENST00000697666.1 | c.140+9805T>C | intron_variant | Intron 3 of 4 | ENSP00000513391.1 |
Frequencies
GnomAD3 genomes AF: 0.374 AC: 56715AN: 151716Hom.: 14062 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
56715
AN:
151716
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.333 AC: 2AN: 6Hom.: 0 Cov.: 0 AF XY: 0.250 AC XY: 1AN XY: 4 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
6
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
4
Gnomad4 AFR exome
AC:
0
AN:
0
Gnomad4 AMR exome
AC:
0
AN:
0
Gnomad4 ASJ exome
AC:
0
AN:
0
Gnomad4 EAS exome
AC:
0
AN:
0
Gnomad4 SAS exome
AC:
0
AN:
0
Gnomad4 FIN exome
AC:
0
AN:
0
Gnomad4 NFE exome
AF:
AC:
2
AN:
6
Gnomad4 Remaining exome
AC:
0
AN:
0
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.374 AC: 56819AN: 151834Hom.: 14102 Cov.: 31 AF XY: 0.369 AC XY: 27384AN XY: 74198 show subpopulations
GnomAD4 genome
AF:
AC:
56819
AN:
151834
Hom.:
Cov.:
31
AF XY:
AC XY:
27384
AN XY:
74198
Gnomad4 AFR
AF:
AC:
0.713927
AN:
0.713927
Gnomad4 AMR
AF:
AC:
0.242754
AN:
0.242754
Gnomad4 ASJ
AF:
AC:
0.311924
AN:
0.311924
Gnomad4 EAS
AF:
AC:
0.152224
AN:
0.152224
Gnomad4 SAS
AF:
AC:
0.299414
AN:
0.299414
Gnomad4 FIN
AF:
AC:
0.231424
AN:
0.231424
Gnomad4 NFE
AF:
AC:
0.249308
AN:
0.249308
Gnomad4 OTH
AF:
AC:
0.323501
AN:
0.323501
Heterozygous variant carriers
0
1438
2875
4313
5750
7188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
968
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at